As always, do your own research | They expect large revenue in Europe by end of this year, assuming approval in April |
---|---|
They're experts in managing and ruining investor psychology | I firmly believe Karyopharm will be bought by a big pharma in not too distant future at a nice premium |
Additionally, prescription demand in the first quarter of 2021 was the highest generated since XPOVIO's initial accelerated FDA approval in July 2019 | This could bode well for the second half |
---|---|
A large investor from the industry was telling me recently, when we were formulating the letter to the board, the kinds of qualities the new CEO must have | That works for a while, then the disease comes back, then a new cocktail is given, and so on |
Also got this note from a biotech friend today: "I wanted to point out that Mark Hoppus of the popular band Blink-182 has been diagnosed with diffuse large B-cell lymphoma.